Who to call at Senti Biosciences Holdings, Inc., and when
Fundz watches for the moments Senti Biosciences Holdings, Inc. starts buying, and tells you who to reach.
- An alert the day Senti Biosciences Holdings, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Senti Biosciences Holdings, Inc., from your own LinkedIn network
Senti Biosciences Holdings, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
sentibio.comAI Executive Summary
AI-powered analysis of 8-K filing content
Dr. Brenda Cooperstone resigned from Senti Biosciences' Board of Directors and her role as Compensation Committee Chair effective immediately on September 23, 2026. The departure was amicable with no disagreements cited, but represents a governance transition that could affect strategic direction.
Key Takeaways
Dr. Brenda Cooperstone resigned from the Board of Directors effective immediately on September 23, 2026
She simultaneously stepped down as Chair of the Compensation Committee
2 more takeaways
Related Filings (3)
3 more filings from Senti Biosciences Holdings, Inc. in the last 90 days
Filing Overview
What This Means
Senti Biosciences Holdings, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.